:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Author:	Mamoor, Shahan
Format:	Recurso digital
Language:
Published:	Zenodo 2025
Online Access:	https://doi.org/10.5281/zenodo.17648788
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An epigenetic module common to the T lymphocyte.
by: Mamoor, Shahan
Published: (2026)

Adirf activation in chronic disease.
by: Mamoor, Shahan
Published: (2025)

NLRP7 engagement in transformation and etiology of chronic disease.
by: Mamoor, Shahan
Published: (2025)

Gpr84 is a marker of the inflammatory bowel disease Crohn's Disease.
by: Mamoor, Shahan
Published: (2026)

Ribosomal activation in TNBC resistance in vitro.
by: Mamoor, Shahan
Published: (2025)

PAXX is activated in aging blood cells.
by: Mamoor, Shahan
Published: (2025)

Chemokine activation during cellular senescence.
by: Mamoor, Shahan
Published: (2024)

Importin 8 is activated in childhood brain cancer.
by: Mamoor, Shahan
Published: (2025)

Leukotriene activation in the blood of humans with high CRP.
by: Mamoor, Shahan
Published: (2025)

ALOX15B activation in ulcerative colitis.
by: Mamoor, Shahan
Published: (2025)

Alox5 activation in the blood of humans with high CRP.
by: Mamoor, Shahan
Published: (2025)

Gasdermin activation during lineage specification in the human embryo.
by: Mamoor, Shahan
Published: (2026)

TSC22D4 gene activation in Crohn's Disease.
by: Mamoor, Shahan
Published: (2025)

NLRP11 detects activation of CIDE cell death effectors.
by: Mamoor, Shahan
Published: (2025)

Arid5b is activated early in human embryonic development.
by: Mamoor, Shahan
Published: (2026)

Genes that function in axon guidance are associated with disease progression in breast and lung cancer.
by: Mamoor, Shahan
Published: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: MSL1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ADGRF1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CD80.
by: Mamoor, Shahan
Published: (2025)

Phosphatase targeting in HER2+ breast cancer to prevent and treat CNS disease: PTPN13.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
by: Mamoor, Shahan
Published: (2026)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
by: Mamoor, Shahan
Published: (2025)

Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
by: Mamoor, Shahan
Published: (2026)

Fam234b is selectively activated during the first cell division of the human embryo.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EIF4G1.
by: Mamoor, Shahan
Published: (2026)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
by: Mamoor, Shahan
Published: (2025)